Clinical Cancer Drugs
Title:Meet Our Editor-in-Chief
Volume: 5
Author(s): Giulio Francia
Affiliation:
Export Options
About this article
Cite this article as:
Francia Giulio , Meet Our Editor-in-Chief, Clinical Cancer Drugs 2018; 5 (2) . https://dx.doi.org/10.2174/2212697X0502190131161027
DOI https://dx.doi.org/10.2174/2212697X0502190131161027 |
Print ISSN 2212-697X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-6988 |
31
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets Post-Transcriptional Control of Selenoprotein Biosynthesis
Current Protein & Peptide Science Future Prospect of RNA Interference for Cancer Therapies
Current Drug Targets Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Current Cancer Drug Targets Recent Advances and Challenges in Adipose Tissue Engineering: Adipose Derived Stem Cell-based Approaches
Current Tissue Engineering (Discontinued) Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Can PPARγ Ligands Be Used in Cancer Therapy?
Current Medicinal Chemistry - Anti-Cancer Agents Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Regulation of Cellular Signal Transduction Pathways by the Extracellular Calcium-Sensing Receptor
Current Pharmaceutical Biotechnology Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Current Molecular Pharmacology Magnetic Resonance Elastography
Current Medical Imaging Mechanisms of CTLA-4-Ig in Tolerance Induction
Current Pharmaceutical Design Recent Advances in Receptor-Targeted Fluorescent Probes for In Vivo Cancer Imaging
Current Medicinal Chemistry Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?
Current Cancer Drug Targets Application of Nanotechnology in Miniaturized Systems and its Use for Advanced Analytics and Diagnostics – an Updated Review
Recent Patents on Food, Nutrition & Agriculture Methods and Applications of Structure Based Pharmacophores in Drug Discovery
Current Topics in Medicinal Chemistry Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Current Diabetes Reviews Prevention and Therapy of Prostate Cancer: An Update on Alternatives for Treatment and Future Perspectives
Current Drug Therapy Flavonoid-Based Cancer Therapy: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
Current Drug Targets